fashion -WSS

fashion

author：Wikipedia 2025-09-27 14:01:46 - browse：917

The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion less next year. Adobe

The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion less next year, a cut that’s more than eight times larger than the one proposed in April.

The Centers for Medicare and Medicaid Services originally said it would cut payments meant to help safety net hospitals by $115 million in 2024. In the final rule released this week, however, that cut grew to $957 million. The pool of money is known as Medicare’s disproportionate share hospital (DSH) payments and uncompensated care payments.

The agency finalized a bigger cut because it lowered its estimated uninsured rate for next year. CMS explained that even though Medicaid enrollment will shrink as states redetermine members’ eligibility, many of those who didn’t lose Medicaid coverage during the pandemic have since gotten or will get insurance from other sources, like employers — and therefore they will remain insured even when they’re kicked off Medicaid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： WATCH: Why do bright lights make us see spots?

focus

WSS

Study: New antibiotic targets gonorrhea as well as last existing drug

FDA approves Recor Medical high blood pressure device

IRA could hurt research into orphan drugs for rare diseases

Diverse clinical trials: Why aren’t we there yet?

PEPFAR is under serious threat — and so is global health

Senate panel clears PBM, hopsital reforms

explore

fashion

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Acelyrin, a rare IPO success, stumbles in its first big test

Affirmative action in medical school literally saved lives

Diverse clinical trials: Why aren’t we there yet?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Diverse clinical trials: Why aren’t we there yet?

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA panel endorses Alnylam’s heart drug — after picking it apart

Moonlake's readout produced a cash windfall. Risks remain

Diverse clinical trials: Why aren’t we there yet?

leisure time

Private equity could exacerbate cardiology's overuse problem, experts fear

Will General Catalyst be the first of many hospital takeovers?

FDA approves potent Eli Lilly obesity drug, Zepbound

A clever new way to fix Medicaid and graduate medical education

FDA panel endorses Alnylam’s heart drug — after picking it apart

New Covid vaccine is recommended for everyone 6 months or older

entertainment

hotspot

focus

focus